Phase III safety data for lifitegrast treatment of adult dry eye disease released by Shire
Summary data from a US-based double-blind placebo controlled phase III study has reported no ocular or treatment-related serious adverse events for lifitegrast in the treatment… Read More »Phase III safety data for lifitegrast treatment of adult dry eye disease released by Shire